Skip to main content
Insight Brief

How to Save an At-Risk Clinical Trial

How can you rescue an at-risk clinical trial without compromising quality? Delays in clinical research are common and cost pharmaceutical companies exorbitant amounts of money. Four in five clinical trials experience delays, with 94% of trials delayed more than a month—creating a potential financial impact of more than $600,000 daily.1 

In this insight brief, Science 37 Chief Delivery Officer, Darcy Forman details how a virtual site (Metasite) is the premier strategy for rescuing an at-risk clinical trial- resulting in faster recruitment and streamlined operations. 


1 Article from Drug Development & Drug delivery